Bioequivalence and Bioavailability Forum

Subject	Author	Posted	Rep.	last R.	Views
Requesting data for a publication 📥 ♻️ 🚀 📌 Requesting data for a presentation	Helmut	2021-04-08 17:09	1	2023-02-23 10:46	20,848
Calculation of PE and 90% CI No ‘R1’ and ‘R2’ in replicate designs No ‘R1’ and ‘R2’ in replicate designs Rose is a rose is a rose is a rose No ‘R1’ and ‘R2’ in replicate designs	Brus	2023-06-14 16:34	4	2023-06-19 19:42	705
within subject standard deviation in fully replicate design if carry over effect is present within subject standard deviation in fully replicate design if carry over effect is present within subject standard deviation in fully replicate design if carry over effect is present within subject standard deviation in fully replicate design if carry over effect is present within subject standard deviation in fully replicate design if carry over effect is present within subject standard deviation in fully replicate design if carry over effect is present	Ankit Parikh	2023-06-08 13:54	5	2023-06-14 10:37	783
average bioequivalence: MLE vs. REML average bioequivalence: MLE vs. REML average bioequivalence: MLE vs. REML average bioequivalence: MLE vs. REML	Mahmoud	2023-03-11 12:21	3	2023-03-16 23:51	1,170
Variance VS Coefficient of variation s² ↔ CV CV ≈ s for low variances CV ≈ s for low variances CV ≈ s for low variances	Imph	2023-02-27 09:09	4	2023-03-06 12:42	1,357
Are Statistical Analysis Plans “required” for Pivotal Studies? SAP vs. part of the clinical protocol SAP vs. part of the clinical protocol Traceability Are Statistical Analysis Plans “required” for Pivotal Studies? Are Statistical Analysis Plans “required” for Pivotal Studies?	Sereng	2023-02-08 18:23	5	2023-02-16 06:55	1,696
Pharmacokinetic and statistical analysis in bioequivalence while maintaining the blind Blinded NCA in Phoenix/WinNonlin Blinded NCA in Phoenix/WinNonlin Blinded NCA in Phoenix/WinNonlin Pharmacokinetic and statistical analysis in bioequivalence while maintaining the blind Phoenix: Locked Workflows Phoenix: Locked Workflows Blind forever? Blind forever?	Imph	2023-02-12 08:31	8	2023-02-15 11:00	1,446
How to calculate Within-subject variability in a replicated BE Models, models!	Brus	2022-12-25 09:21	1	2022-12-25 12:17	1,525
Confidence intervals Confidence intervals	Bebac user	2022-12-19 13:59	1	2022-12-21 21:11	1,550
Observations in a linear model Observations in a linear model Observations in a linear model Observations in a linear model And the Oscar goes to: Replicates! It's all in the df's	Helmut	2022-11-15 10:55	5	2022-11-18 17:28	2,053
Parameter affecting Subject by formulation	Mithu	2022-06-07 09:12	0		779
Defining time to concentration threshold Defining time to concentration threshold I prefer interpolation I prefer interpolation Continuous variable → mean	Cytokrom C	2022-04-29 16:24	4	2022-05-01 22:05	1,653
IWRES and NPDE vs time/concentration plots interpretation IWRES and NPDE vs time/concentration plots interpretation	jmt3	2022-04-03 08:25	1	2022-04-05 07:56	1,295
Adjusting weight to reflect group differences in Model Adjusting weight to reflect group differences in Model Adjusting weight to reflect group differences in Model Adjusting weight to reflect group differences in Model	balakotu	2022-03-29 11:24	3	2022-03-30 09:19	1,547
Normal distribution assessment Normal distribution assessment Normal distribution assessment Testing ‘randomness’ Normal distribution assessment	BE-proff	2022-02-20 19:07	4	2022-02-27 17:49	1,659